Lymphoma, Primary Effusion
"Lymphoma, Primary Effusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.
MeSH Number(s)
C04.557.386.480.150.592
C15.604.515.569.480.150.592
C20.683.515.761.480.150.592
Concept/Terms
Lymphoma, Primary Effusion- Lymphoma, Primary Effusion
- Effusion Lymphoma, Primary
- Effusion Lymphomas, Primary
- Lymphomas, Primary Effusion
- Primary Effusion Lymphomas
- Primary Effusion Lymphoma
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Primary Effusion".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Primary Effusion".
This graph shows the total number of publications written about "Lymphoma, Primary Effusion" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Primary Effusion" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Lymphoma, Primary Effusion" by people in Profiles.
-
KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle. J Virol. 2023 03 30; 97(3):e0176322.
-
Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells. Cancer Immunol Immunother. 2022 Oct; 71(10):2497-2509.
-
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma. Cancer Immunol Immunother. 2022 May; 71(5):1017-1031.
-
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nat Commun. 2020 12 09; 11(1):6318.
-
Clinicopathologic characteristics and survival of patients with primary effusion lymphoma. Leuk Lymphoma. 2020 09; 61(9):2093-2102.
-
Extracavitary primary effusion lymphoma presenting as a thalamic mass in a patient with multicentric Castleman disease. Blood. 2020 04 02; 135(14):1190.
-
Reconsideration of the first recognition of breast implant-associated anaplastic large cell lymphoma: A critical review of the literature. Ann Diagn Pathol. 2020 Apr; 45:151474.
-
EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus. J Virol. 2019 08 01; 93(15).
-
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. J Clin Invest. 2017 Jun 01; 127(6):2066-2080.
-
Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses. PLoS Pathog. 2015 Jul; 11(7):e1005064.